Enantioselective carbonyl reduction of eperisone in human liver microsomes

References

• Bálint J, Egri G, Markovits I, Czugler M, Marthi K, Demeter Á, Temesvári-Takács K, Fogassy E. (2001). Synthesis of some tolperisone metabolites in racemic and optically active form. Tetrahedron: Asymmetry 12:3417–3422.
   Google Scholar
• Barf T, Vallgårda J, Emond R, Häggström C, Kurz G, Nygren A, Larwood V, Mosialou E, Axelsson K, Olsson R, Engblom L, Edling N, Rönquist-Nii Y, Ohman B, Alberts P, Abrahmsén L. (2002). Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1. J Med Chem 45:3813–3815.
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U, Martin HJ, Ernst M, Maser E. (2004). Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver. Drug Metab Dispos 32:915–922.
   PubMed Web of Science ®Google Scholar
• Felsted RL, Bachur NR. (1980). Mammalian carbonyl reductases. Drug Metab Rev 11:1–60.
   PubMed Web of Science ®Google Scholar
• Forrest GL, Gonzalez B. (2000). Carbonyl reductase. Chem Biol Interact 129:21–40.
   PubMed Web of Science ®Google Scholar
• Fujita T, Takamatsu T, Hisamoto T, Tsutsumi J, Kinoshita K, Kanai T. (1981). Studies on the metabolic fate of 4′-Ethyl-2-methyl-3-piperidinopropiophenone hydrochloride (1): Absorption, distribution and excretion in rats and guinea pigs. Pharmacometrics 21:835–846.
   Google Scholar
• Furuta Y, Yoshikawa A. (1976). Reversible adrenergic α-receptor blocking action of 2,4′-dimethyl-3-piperidino-propiophenone (tolperisone). Jpn J Pharmacol 26:543–550.
   PubMedGoogle Scholar
• Hasegawa Y, Kaku S, Araki H, Otomo S. (1992). Sigma receptor modulation of the muscle relaxant action of eperisone. Eur Neuropsychopharmacol 2:157–159.
   PubMedGoogle Scholar
• Hoffmann F, Maser E. (2007). Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily. Drug Metab Rev 39:87–144.
   PubMed Web of Science ®Google Scholar
• Jin Y, Penning TM. (2007). Aldo-keto reductases and bioactivation/detoxication. Annu Rev Pharmacol Toxicol 47:263–292.
   PubMed Web of Science ®Google Scholar
• Kim SH, Ramu R, Kwon SW, Lee SH, Kim CH, Kang SK, Rhee SD, Bae MA, Ahn SH, Ha DC, Cheon HG, Kim KY, Ahn JH. (2010). Discovery of cyclicsulfonamide derivatives as 11 β-hydroxysteroid dehydrogenase 1 inhibitors. Bioorg Med Chem Lett 20:1065–1069.
   PubMed Web of Science ®Google Scholar
• Malátková P, Maser E, Wsól V. (2010). Human carbonyl reductases. Curr Drug Metab 11:639–658.
   PubMed Web of Science ®Google Scholar
• Maser E, Stinner B, Atalla A. (2000). Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytosolic enzymes in human liver and lung. Cancer Lett 148:135–144.
   PubMed Web of Science ®Google Scholar
• Maser E, Friebertshäuser J, Völker B. (2003). Purification, characterization and NNK carbonyl reductase activities of 11β-hydroxysteroid dehydrogenase type 1 from human liver: Enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen. Chem Biol Interact 143-144:435–448.
   PubMed Web of Science ®Google Scholar
• Maser E, Wsol V, Martin HJ. (2006). 11β-hydroxysteroid dehydrogenase type 1: Purification from human liver and characterization as carbonyl reductase of xenobiotics. Mol Cell Endocrinol 248:34–37.
   PubMed Web of Science ®Google Scholar
• Matsunaga M, Uemura Y, Yonemoto Y, Kanai K, Etoh H, Tanaka S, Atsuta Y, Nishizawa Y, Yamanishi Y. (1997). Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats. Jpn J Pharmacol 73:215–220.
   PubMedGoogle Scholar
• Mihara K, Matsumura M, Yoshioka E, Hanada K, Nakasa H, Ohmori S, Kitada M, Ogata H. (2001). Intestinal first-pass metabolism of eperisone in the rat. Pharm Res 18:1131–1137.
   PubMed Web of Science ®Google Scholar
• Sakitama K, Ozawa Y, Aoto N, Tomita H, Ishikawa M. (1997). Effects of a new centrally acting muscle relaxant, NK433 (lanperisone hydrochloride) on spinal reflexes. Eur J Pharmacol 337:175–187.
   PubMed Web of Science ®Google Scholar
• Skálová L, Nobilis M, Szotáková B, Kondrová E, Savlík M, Wsól V, Pichard-Garcia L, Maser E. (2002). Carbonyl reduction of the potential cytostatic drugs benfluron and 3,9-dimethoxybenfluron in human in vitro. Biochem Pharmacol 64:297–305.
   PubMed Web of Science ®Google Scholar
• Staab CA, Maser E. (2010). 11β-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. J Steroid Biochem Mol Biol 119:56–72.
   Google Scholar
• Takamatsu T, Horie T, Tsutsumi J, Kanai T. (1993). The metabolism of eperisone hydrochloride in laboratory animals and man. IyakuhinKenkyu 24:520–532. (In Japanese).
   Google Scholar
• Tanaka K, Kaneko T, Yamatsu K. (1981). [Effects of 4′ethyl-2-methyl-3-piperidinopropiophenone on experimental rigidity and spinal cord activities (author’s transl)]. Nippon Yakurigaku Zasshi 77:511–520.
   PubMed Web of Science ®Google Scholar
• Wermuth B. (1985). Aldo-keto reductases. Prog Clin Biol Res 174:209–230.
   PubMedGoogle Scholar
• Wsól V, Szotáková B, Skálová L, Maser E. (2003). Stereochemical aspects of carbonyl reduction of the original anticancer drug oracin by mouse liver microsomes and purified 11β-hydroxysteroid dehydrogenase type 1. Chem Biol Interact 143-144:459–468.
   PubMed Web of Science ®Google Scholar
• Wsól V, Szotáková B, Skálová L, Maser E. (2004). The novel anticancer drug oracin: Different stereospecificity and cooperativity for carbonyl reduction by purified human liver 11β-hydroxysteroid dehydrogenase type 1. Toxicology 197:253–261.
   PubMed Web of Science ®Google Scholar
• Yoo HH, Kim NS, Lee J, Sohn DR, Jin C, Kim DH. (2009). Characterization of human cytochrome P450 enzymes involved in the biotransformation of eperisone. Xenobiotica 39:1–10.
   PubMed Web of Science ®Google Scholar
• Zsila F, Hollósi M, Gergely A. (2000). Stereochemical study of tolperisone, a muscle relaxant agent, by circular dichroism and ultraviolet spectroscopy. Chirality 12:720–726.
   PubMedGoogle Scholar